Will Atossa Genetics (USA Stocks:ATOS) volatility gain before April

All Stories . Risk . 
Aina Ster .  Story
ATOS Stock  USD 0.67  0.01  1.52%   
Aina Ster
By Aina Ster
Macroaxis Story
It appears Atossa Genetics may not recover as fast as we have hopped for as its price went down 0.56% today. The company current daily volatility is 4.97 percent, with a beta of 0.66 and an alpha of 0.02 over Dow Jones Industrial. Whilst many millenniums are getting more into investing against high market volatility, it is quite pruden to review Atossa Genetics based on its historical prices. What exactly are Atossa Genetics shareholders getting in April?
Published over two weeks ago
View all stories for Atossa Genetics | View All Stories
Macroaxis uses a strict editorial review process to publish our stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Raphi Shpitalnik

Atossa Genetics currently holds roughly 125.54 M in cash with (16.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.99, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Investing in Atossa Genetics, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Atossa Genetics along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Atossa Genetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Atossa Genetics in the context of predictive analytics.
Hype
Prediction
Details
Intrinsic
Valuation
Details
1 Analysts
Consensus
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Atossa Genetics. Your research has to be compared to or analyzed against Atossa Genetics' peers to derive any actionable benefits. When done correctly, Atossa Genetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Atossa Genetics.

Watch out for price decline

Please consider monitoring Atossa Genetics on a daily basis if you are holding a position in it. Atossa Genetics is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Atossa Genetics stock to be traded above the $1 level to remain listed. If Atossa Genetics stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.

How important is Atossa Genetics's Liquidity

Atossa Genetics financial leverage refers to using borrowed capital as a funding source to finance Atossa Genetics ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Atossa Genetics financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Atossa Genetics's total debt and its cash.

How does Atossa utilize its cash?

To perform a cash flow analysis of Atossa Genetics, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Atossa Genetics is receiving and how much cash it distributes out in a given period. The Atossa Genetics cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Atossa Genetics Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Atossa Genetics reported Net Cash Flow from Operations of (14.82 Million) in 2022

Atossa Genetics Correlation with Peers

Investors in Atossa can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Atossa Genetics. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Atossa Genetics and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Atossa is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Atossa for more details

A Deeper look at Atossa

We consider Atossa Genetics dangerous. Atossa Genetics secures Sharpe Ratio (or Efficiency) of 0.0266, which signifies that the company had 0.0266% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-seven technical indicators for Atossa Genetics, which you can use to evaluate the future volatility of the firm. Please confirm Atossa Genetics Mean Deviation of 3.54, risk adjusted performance of 0.0102, and Downside Deviation of 4.09 to double-check if the risk estimate we provide is consistent with the expected return of 0.13%.
HGGOF
SUM
UNM
PMNXF
SSNT
HGGOF
0.10.110.560.29
HGGOF
SUM
0.10.140.130.36
SUM
UNM
0.110.14-0.450.43
UNM
PMNXF
0.560.13-0.45-0.19
PMNXF
SSNT
0.290.360.43-0.19
SSNT
HGGOF
SUM
UNM
PMNXF
SSNT
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Atossa Genetics has 54 percent chance to drop under USD0.73 in the coming weeks

Atossa Genetics information ratio is up to 0.01. Atossa Genetics shows above-average downside volatility for the selected time horizon. We advise investors to inspect Atossa Genetics further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Atossa Genetics future alpha. Atossa Genetics is a potential penny stock. Although Atossa Genetics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Atossa Genetics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Atossa instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Our Conclusion on Atossa Genetics

Whereas many of the other players in the biotechnology industry are either recovering or due for a correction, Atossa Genetics may not be performing as strong as the other in terms of long-term growth potentials. With a relatively neutral outlook on the newest economy, it is better to hold off any trading of Atossa as the current risk-reward utility is not appealing enough. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Atossa Genetics.

Editorial Staff

Aina Ster is a Member of Macroaxis Editorial Board. Aina delivers weekly perspective on ongoing market and economic trends, analysis and tips from predictive analysis to forecasting across various financial instruments. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of Atossa Genetics. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY